Explore
Search results




Building on lessons learned from the COVID-19 pandemic, there are significant opportunities to expand the use of rapid testing to address many health challenges around the world- from infectious diseases like malaria and HIV to non-infectious health needs like prenatal care. Learn how Abbott is intentionally approaching product development to democratize, decentralize and...

What would happen if genetic sequencing were standard care for undiagnosed diseases? And how can we ensure that the future of genomics benefits everyone, not just the one percent?



Can the data collected through smartphones, wearable sensors, and passive monitoring devices be turned into actionable knowledge about the environmental impacts on our health? Meet three innovative researchers who are using these technologies to unlock the mysteries of Crohn’s disease and more. Presented by the Helmsley Charitable Trust.







Faced with the COVID-19 pandemic, the healthcare industry had to quickly adapt to confront the rapidly evolving challenges facing its patients, customers, and employees. Learn how three key decisions enabled Merck & Co. to accelerate innovation in 2020 and why these lessons will be critical to future success in addressing the most pressing healthcare challenges.

Rick Doblin wants to be a legally licensed psychedelic therapist. Learn about his work using MDMA, or ecstasy, to help people suffering from PTSD.


Strategic Advisor for Environmental and Science Journalism, National Geographic Society